非典型抗精神病药所致食欲增加的生物学机制研究进展
被引量:2
摘要
精神分裂症是一种全球性、易复发性、难治愈性精神疾病,发病原因迄今仍未完全阐明,我国1998年流行病学调查显示分裂症患病率为6.55%,国际研究显示近25年来患病率没有减少Ⅲ。目前多个国家的治疗指南均推荐使用非典型抗精神病药作为精神分裂症患者的首选用药。
出处
《中华行为医学与脑科学杂志》
CAS
CSCD
北大核心
2013年第10期957-958,共2页
Chinese Journal of Behavioral Medicine and Brain Science
基金
中国博士后基金资助项目(2012M520585)
国家自然科学基金资助项目(81271514)
参考文献31
-
1陈昌惠,沈渔笛,张维熙,李淑然,黄悦勤,王金荣,王德平,涂建,宁佐喜,付力牧,纪丽萍,刘志广,吴化民,罗开林,翟书涛,严和,孟国荣.中国七个地区精神分裂症流行病学调查[J].中华精神科杂志,1998,31(2):72-74. 被引量:173
-
2Shivashankar S,Telfer S,Arunagiriraj J,et al.Has the prevalence,clinical presentation and social functioning of schizophrenia changed over the last 25years? Nithsdale schizophrenia survey revisited.Schizophr Res,2013,146:349-356.
-
3Mitchell AJ,Vancampfort D,Sweers K,et al.Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis.Schizophr Bull,2013,39:306-318.
-
4张文跃,祁小飞,杨忠,王梅芬,顾凤华,宣春明,韩晓东.G蛋白β3亚单位基因多态性与抗精神病药源性肥胖的相关性[J].中华行为医学与脑科学杂志,2011,20(12):1101-1103. 被引量:1
-
5De Hert M,Vancampfort D,Correll C U,et al.Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia:systematic evaluation.Br J Psychiatry,2011,199:99-105.
-
6Vancampfort D,Vansteelandt K,Correll CU,et al.Metabolic syndrome and metabolic abnormalities in bipolar disorder:a meta-analysis of prevalence rates and moderators.Am J Psychiatry,2013,170:265-274.
-
7Basson BR,Kinon B J,Taylor CC,et al.Factors influencing acute weight change in patients with schizophrenia treated with olanzapine,haloperidol,or risperidone.J Clin Psychiatry,2001,62:231-238.
-
8Kinon B J,Kaiser C J,Ahmed S,et al.Association between early and rapid weight gain and change in weight over one year of olanzapine therapy in patients with schizophrenia and related disorders.J Clin Psychopharmacol,2005,25:255-258.
-
9Gothelf D,Falk B,Singer P,et al.Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine.Am J Psychiatry,2002,159:1055-1057.
-
10Theisen FM,Linden A,K(o)nig IR,et al.Spectrum of binge eating symptomatology in patients treated with clozapine and olanzapine.J Neural Transm,2003,110:111-121.
二级参考文献31
-
1施辉,徐晶宇,赵汉清,纪菊英,徐乐平,朱静,孙剑.2132例首次接受治疗精神分裂症患者糖尿病患病率调查[J].中国行为医学科学,2007,16(5):438-438. 被引量:6
-
2中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
-
3Baptista T,Kin NM,Beaulieu S,et al.Obesity and related metabolic abnormalities during antipsychotic drug administration:mechanisms,management and research perspectives.Pharmacopsychiatry,2002,35:205-219.
-
4Sifftert W,Forster P,Jockel KH,et al.Worldwide ethnic distribution of G protein beta3 subunit 825T allele and its association with obesity in Caucasian,Chinese,and Black African individuals.J Am Soc Nephrol,1999,10:1921-1930.
-
5Bishop JR,Ellingrod VL,Moline J,et al.Pilot study of G-protein beta3 subunit gene (C825T) polymorphism and clinical response to olanzapine or olanzapine-related weight gain in persons with schizophrenia.Med Sci Monit,2006,12:47-50.
-
6Wang YC,Bai YM,Chen JY,et al.C825T polymorphism in human G protein beta3 subunit gene is associated with long-term clozapine treatment-induced body weight change in Chinese population.Pharmacogenet Genomics,2005,15:743-748.
-
7Ujike H,Nomura A,Morita Yet al.Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients:a cohort study.J Clin Psychiatry,2008,69:1416-1422.
-
8Park YM,Chung YC,Lee SH,et al.G-protein beta3 subunit gene 825C/T polymorphism is not associated with olanzapine-induced weight gain in Korean schizophrenic patients.Psychiatry Invest,2009,6:39-43.
-
9Ryden M,Faulds G,Hoffstedt J,et al.Effect of the (C825T) G beta (3) polymorphism on adrenoceptor-mediated lipolysis in human fat cell.Diabetes,2002,51:1601-1608.
-
10Nasrallah H.A review of the effect of atypical antipsychotics on weight.Psychoneuroendocrinology,2003,28 (suppl 1):83-96.
共引文献186
-
1钟书铭,郑洪波.精神分裂症流行病学研究进展[J].医学信息(医学与计算机应用),2014,0(23):681-683. 被引量:6
-
2卢冬艳,郑洪波.精神障碍流行病学调查的研究概况[J].医学信息(医学与计算机应用),2014,0(23):680-681. 被引量:1
-
3王占敏,李喜泼.保定市精神病性障碍的流行病学调查[J].中国健康心理学杂志,2008,16(5):542-544.
-
4孙长军,徐良琴.住院癔症病例20年临床分析[J].中国医药导报,2006,3(2):20-21.
-
5钱敏才,陈海支,陆炜,王春生,杨胜良,费锦锋,沈鑫华,杨剑虹.浙江省精神病专科医院住院患者用药现状调查[J].中华临床医师杂志(电子版),2011,5(23):7124-7126. 被引量:1
-
6胡存安.精神分裂症的发病相关因素[J].神经疾病与精神卫生,2004,4(3):238-240. 被引量:3
-
7卢小勇,陈贺龙,胡斌,陈宪生,邹国华,周平良,李正春,吴书华,匡奕华,刘平,刘增裕,陈点火,刘快发,周国治,李春芳,朱安雄.江西省精神分裂症患病率流行病学调查[J].上海精神医学,2004,16(4):234-236. 被引量:13
-
8江道群.心理护理对神经症患者住院满意度的影响[J].四川医学,2004,25(10):1160-1161.
-
9司天梅,舒良,于欣,马崔,王高华,白培深,刘协和,纪丽萍,师建国,陈宪生,梅其一,栗克清,张鸿燕,马弘.10省市抗精神病药使用现况的调查[J].中华精神科杂志,2004,37(3):152-155. 被引量:95
-
10邹自英,胡晓莉,黄海,赵碧.我国精神健康的现状、预防和控制进展[J].西南军医,2004,6(5):36-38. 被引量:1
同被引文献40
-
1刘福权,陈大春,李瑛,高淑英,张国玲,柏林,柴佳宝,王阳,宋佳起,赵青,倪海清.精神分裂症共病超重或肥胖的临床特征及风险因素[J].中国健康心理学杂志,2020,0(3):328-332. 被引量:8
-
2Dockray GJ. Gastrointestinal hormones and the dialogue between gut and brain[J] J Physiol,2014,592(Ptl4) :2927-2941.
-
3Mietlicki-Baase EG, Ortinski PI, Rupprecht LE, et at. The food intake- suppressive effects of glucagon-like peptide-I receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors [ J]. Am J Physiol Endocrino| Metab,2013,305( 11 ) :E1367-1574.
-
4Engel JA,Jerlhag E.Alcohol: mechanisms along the mesolimbic dopa- mine system[J]. Prog Brain Res,2014,211 ( 1 ) :201-233.
-
5Kedia G, Mussweiler T, Linden DE. Brain mechanisms of social com- parison and their influence on the reward system [ J ]. Neuroreport, 2014,25(16) : 1255-1265.
-
6Olds J, Milner P.Positive reinforcement produced by electrical stimula- tion of septal area and other regions of rat brain [J]. J Comp PhysiolPsychol, 1954,47(6) :419-427.
-
7Radovanovic CA, Santos LA, Carvalho MD, et al. Arterial Hyperten- sion and other risk factors associated with cardiovascular diseases a- mong adults [J]. Rev Lat Am Enfermagem,2014,22{4) :547-553.
-
8Bidgoli SA ,Jahari N, Zavarhei MD. Prostate-specific antigen levels in relation to background factors: are there links to endocrine disrupting chemicals and AhR expression? [ J ] .Asian P ac J Cancer Prey, 2014, 15(15) :6121-6125.
-
9Mear Y, Blanchard MP, Defilles C, et al.Ghrelin receptor (GHS-Rla) and its constitutive activity in somatotroph adenomas: a new co-targe- ting therapy using GHS-Rla inverse agonists and somatostatin analogs [J]. J Clin Endocrinol Metah.2014 [Elub ahead of print].
-
10Harris G, Shen Y, Ha H, et al. Dissecting the signaling mechanisms underlying recognition and preference of food odors [ J ]. J Neuresci, 2014,34(28) :9389-9403.
引证文献2
-
1栾晓,徐珞.Ghrelin对大鼠摄食选择的影响及机制[J].中华行为医学与脑科学杂志,2015,24(1):4-7. 被引量:1
-
2刘彦丽,张伟波,何思源,徐韦云,周卿,蒋怡华,张宴萍,蔡军.上海市社区精神分裂症患者超重或肥胖的相关因素分析[J].上海预防医学,2023,35(5):426-432.
-
1刘裴.米氮平与万拉法新治疗抑郁症对照研究[J].健康心理学杂志,2004,12(1):15-15. 被引量:2
-
2余银亮,翁赛峥,邓泓,占家铣,林巧,郝楷荣,郭少楠,罗兰珠,魏敏,高明.奥氮平所致食欲增加对代谢指标的影响[J].临床合理用药杂志,2017,10(1):82-83. 被引量:1
-
3王丹,何浪.手性与手性药物[J].成都医学院学报,2006,1(2):155-157. 被引量:2
-
4郑燕.植物雌激素及其对人体健康的影响[J].中国基层医药,2009,16(7):1330-1331.
-
5杜彪,赵东国.齐拉西酮与奥氮平治疗精神分裂症的安全性系统评价[J].中国药学杂志,2011,46(13):1046-1048. 被引量:4
-
6祁鑫川,韩洁.喹硫平与肥胖[J].今日健康,2014,13(9):358-358.
-
7张吉营,吴文辉,赵红苏,高静芳.喹硫平合用抗抑郁剂治疗抑郁症的临床评价[J].中国医院药学杂志,2009,29(2):137-139. 被引量:9
-
8韩轶超,彭晔,杨秀芳,谢娜.多西他赛联合奥沙利铂治疗晚期胃癌的临床观察[J].华西医学,2014,29(11):2055-2058. 被引量:3
-
9夏筱禹.重组人促红细胞生成素治疗肾性贫血的临床疗效分析[J].海峡药学,2013,25(6):151-152. 被引量:2
-
10陈浩,刘京惠.米氮平与草酸艾司西酞普兰治疗老年期抑郁症的对照观察[J].检验医学与临床,2015,12(1):66-67. 被引量:9